8-K filing — KALA BIO, Inc. (KALA)
Filed: 2026-09-10 AccNo: 0001829126-26-009999 Size: 454 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Stocks · News reference
8-K filing — KALA BIO, Inc. (KALA)
Filed: 2026-09-09 AccNo: 0001829126-26-009946 Size: 198 KB Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Item 8.01: Other Events
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Kala Bio And Virotek Finalizes Definitive Exclusive Distribution And Reseller Agreement And Related Quality, Brand, And Data Protection Agreements
Kala Bio, Inc. (NASDAQ:KALA) ("Kala") and Virotek Inc. ("Virotek") today announced that they have finalized a definitive exclusive distribution and reseller agreement (the "Agreement") and
KALA BIO shares are trading lower. The company announced it has entered into a letter of intent with Virotek.
Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.58% to 52,876.43 while the NASDAQ dipped 1.40% to